Brief: Theradiag Provides Update On Prestizia And Its Partnership With HOB Biotech

Theradiag SA

19/12/2017 17:04

Dec 19 (Reuters) - THERADIAG SA  ALTHE.PA : 
    * DISCONTINUATION OF ITS PRESTIZIA RESEARCH ACTIVITY, A 
WHOLLY-OWNED SUBSIDIARY OF THERADIAG 
    * SAYS CONTRACTS RENEGOTIATION DISCUSSIONS INITIATED BY HOB 
BIOTECH REACHED AN IMPASSE 
    * SAYS IT'S NOT POSSIBLE AT THIS STAGE TO ANTICIPATE 
CONSEQUENCES 
OF SITUATION ON HOB BIOTECH PARTNERSHIP 
    * SAYS IT'S NOT POSSIBLE AT THIS STAGE TO ANTICIPATE 
CONSEQUENCES 
OF SITUATION ON LAUNCH OF BIOCLIA 
 
Source text for Eikon:  ID:nNDL1TlvG2  
Further company coverage:  ALTHE.PA  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))